Amyotrophic Lateral Sclerosis
FY22 Therapeutic Idea Award
The list of Fiscal Year 2022 Amyotrophic Lateral Sclerosis Research Program Therapeutic Idea Award applications recommended for funding is for informational purposes only. Identification on the list of applications recommended for funding is not intended to either confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.
Institution | Principal Investigator |
---|---|
AcuraStem, Inc. | Wen-Hsuan Chang |
Ben-Gurion University of the Negev | Stanislav Engel |
Buck Center for Research on Aging | Claudio Hetz |
Centre Europeen de Recherche en Biologie et en Medecine | Nicolas Charlet-Berguerand |
Duquesne University | Devika Soundara Manickam |
Formation Venture Engineering Foundry, Inc. | Ajay Verma |
Murdoch University | Sarah Rea |
Novaton Pharmaceuticals, Inc. | Dominque Cheneval |
Seal Rock Therapeutics, Inc. | Johannes Grosse |
St. Joseph's Hospital and Medical Center | David Medina |
Technion Research and Development Foundation, Ltd. | Reut Shalgi |
Thomas Jefferson University | Amit Srivastava Davide Trotti |
University at Albany, SUNY | Li Niu |
University of British Columbia | Max Cynader |
University of California, San Francisco | Daniel Mordes |
University of Florida | Laura Ranum |
University of Illinois at Chicago | Fei Song |
University of Maryland, Baltimore | Tim Luetkens |
University of North Carolina at Chapel Hill | Alison Axtman |
University of Southern California | Justin Ichida |
Van Andel Research Institute | Qiang Zhu |
Washington University in St. Louis | Timothy Miller |
Last updated Thursday, December 1, 2022